Short Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Expands By 121.2%

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 1,039,200 shares, a growth of 121.2% from the February 13th total of 469,800 shares. Approximately 0.5% of the company’s shares are short sold. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 5,196.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Recordati Industria Chimica e Farmaceutica stock opened at $55.54 on Friday. The company has a market capitalization of $11.46 billion, a PE ratio of 27.77 and a beta of 0.30. Recordati Industria Chimica e Farmaceutica has a 12 month low of $52.25 and a 12 month high of $52.25. The stock has a 50-day moving average price of $55.54 and a two-hundred day moving average price of $53.49.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.